Below are the financial statements of Sundrug, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of JPY | 2025 | 2024 |
|---|---|---|
| Current assets | — | — |
| Cash and deposits | 64,956b | 69,698b |
| Accounts receivable - trade | 29,994b | 26,740b |
| Merchandise | 98,413b | 90,970b |
| Supplies | 261b | 322b |
| Accounts receivable - other | 18,390b | 15,900b |
| Other | 4,762b | 4,610b |
| Total current assets | 216,777b | 208,243b |
| Property, plant and equipment | — | — |
| Buildings and structures | 154,450b | 136,203b |
| Accumulated depreciation | -57,344b | -51,182b |
| Buildings and structures, net | 97,106b | 85,020b |
| Land | 8,616b | 8,514b |
| Other | 85,734b | 74,117b |
| Accumulated depreciation | -54,751b | -47,116b |
| Other, net | 30,983b | 27,000b |
| Total property, plant and equipment | 136,706b | 120,536b |
| Intangible assets | — | — |
| Goodwill | 1,440b | 1,556b |
| Other | 7,228b | 7,587b |
| Total intangible assets | 8,669b | 9,143b |
| Investments and other assets | — | — |
| Investment securities | 34,013b | 35,808b |
| Long-term loans receivable | 7,364b | 7,645b |
| Deferred tax assets | 9,016b | 8,155b |
| Deferred tax assets for land revaluation | 820b | 796b |
| Leasehold and guarantee deposits | 28,411b | 27,828b |
| Other | 2,231b | 2,149b |
| Allowance for doubtful accounts | -4b | -98b |
| Total investments and other assets | 81,853b | 82,284b |
| Total non-current assets | 227,229b | 211,964b |
| Total assets | 444,007b | 420,208b |
| Current liabilities | — | — |
| Accounts payable - trade | 79,731b | 77,371b |
| Short-term borrowings | 1,000b | 35,000b |
| Current portion of long-term borrowings | 3,800b | 0b |
| Income taxes payable | 8,180b | 7,547b |
| Contract liabilities | 6,993b | 5,982b |
| Other | 28,801b | 29,565b |
| Total current liabilities | 128,507b | 155,466b |
| Non-current liabilities | — | — |
| Long-term borrowings | 33,866b | 0b |
| Provision for retirement benefits for directors (and other officers) | 281b | 315b |
| Retirement benefit liability | 2,102b | 2,158b |
| Asset retirement obligations | 7,029b | 6,644b |
| Other | 2,505b | 2,533b |
| Total non-current liabilities | 45,785b | 11,651b |
| Total liabilities | 174,293b | 167,118b |
| Shareholders’ equity | — | — |
| Capital | 3,931b | 3,931b |
| Capital surplus | 7,533b | 7,496b |
| Retained earnings | 263,754b | 247,272b |
| Treasury shares | -3,868b | -3,894b |
| Total shareholders’ equity | 271,350b | 254,806b |
| Accumulated other comprehensive income | — | — |
| Valuation difference on available-for-sale securities | 17b | 139b |
| Revaluation reserve for land | -1,782b | -1,805b |
| Remeasurements of defined benefit plans | 128b | -50b |
| Total accumulated other comprehensive income | -1,636b | -1,716b |
| Total net assets | 269,713b | 253,090b |
| Total liabilities and net assets | 444,007b | 420,208b |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sundrug’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.